Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life
In this retrospective study, we intended to investigate the baseline fracture risk profile in patients who started treatment with different anti-osteoporotic medications. We analyzed retrospectively the fracture risk calculated with DeFRA, a validated FRAX derived tool, in women who started an anti-...
Saved in:
Main Authors: | G. Adami (Author), A. Giollo (Author), M. Rossini (Author), G. Orsolini (Author), C. Benini (Author), O. Viapiana (Author), D. Gatti (Author), A. Fassio (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteoporotic fractures
by: M. Rossini, et al.
Published: (2002) -
Vitamin D and disease severity in coronavirus disease 19 (COVID-19)
by: G. Adami, et al.
Published: (2021) -
A case of mandible Paget's disease of the bone treated with intravenous neridronate
by: A. Fassio, et al.
Published: (2016) -
Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture
by: Rossini M, et al.
Published: (2013) -
Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement
by: G. Adami, et al.
Published: (2023)